Skip to content

Encouragement-induced Movement Therapy in Daily Life

Encouragement-induced Movement Therapy in Daily Life - a Randomized Controlled, Assessor-blinded Multi-center Trial in Stroke Patients With a Unilateral Hemiparesis, Using a Wrist-worn Tracking and Feedback Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03294187
Acronym
ISEAR
Enrollment
42
Registered
2017-09-26
Start date
2017-09-25
Completion date
2021-11-25
Last updated
2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Upper Extremity, Feedback, Rehabilitation, Randomized Controlled Trial

Brief summary

Stroke places a major burden on health care and society. It often leads to a hemiparesis. Intensive stroke rehabilitation speeds up recovery. In daily practice, the financial and/or human resources to provide this intensive rehabilitation are often lacking. Applying modern-day tracking and feedback technology to encourage a self-administered, context specific training is expected to offer significant potential to increase intensity of practice. Up until now, there has been no randomized trial examining the effect of such an intervention on daily arm usage. The primary objective of this study is to determine the effect of wearing an activity tracking and multimodal feedback device for six weeks on self-reported daily life use of the paretic arm after stroke, when compared to control group stroke subjects wearing a hardware-wise identical sham device providing no feedback. The secondary aim is to examine compliance to use the device and the quantitative, qualitative and functional improvement of the paretic arm. It is hypothesized that participants in the experimental group show a higher change in self-reported daily life use of the paretic arm when compared to the control group both post intervention and at 6-week follow-up. ISEAR is a multicenter, assessor-blinded randomized controlled trial of 62 subjects beyond the first 3 months poststroke.

Interventions

DEVICEWrist-worn wearables

See arm/group description.

Sponsors

Tyromotion AG
CollaboratorUNKNOWN
Swiss Federal Institute of Technology in Zurich (ETH Zurich)
CollaboratorUNKNOWN
University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Above 18 years of age with unilateral stroke and residual hemiparesis leading to a decrease of arm function after completion of all inpatient rehabilitation (at least 90 days post stroke) * Ability to lift arm against gravity (\>30 degrees flexion or abduction) * Ability to don/doff the devices on both wrists independently or with assistance of a caregiver * Ability to give informed consent as documented by signature

Exclusion criteria

* Major untreated depression * Severe cognitive impairment * Suffering from comprehensive aphasia * Severely impaired sensation (unable to feel a soft touch on the dorsal side of their paretic wrist with closed eyes) * Other major comorbidities (e.g., cardiopulmonary disease, renal failure, hepatic dysfunction, orthopedic disorders, etc.) * Expected hospitalization during study period * Known intolerance to device material * Known or suspected non-compliance, drug or alcohol abuse * The investigator, his/her family members, employees, and other dependent persons

Design outcomes

Primary

MeasureTime frameDescription
Motor Activity Log - 14, Amount of Use sub scalePost-intervention (6 weeks)Self-reported amount of upper limb use in daily life

Secondary

MeasureTime frameDescription
Modified Rankin ScalePost-intervention (6 weeks)Global Disability
EuroQol five dimensions five levels questionnairePost-intervention (6 weeks)Quality of Life
Motor Activity Log - 14, Quality of Movement sub scalePost-intervention (6 weeks)Self-reported quality of upper limb use in daily life
Motor Activity Log - 14, Amount of Use sub scaleFollow-up (12 weeks)Self-reported amount of upper limb use in daily life
Fugl-Meyer Assessment, Upper Extremity sub scalePost-intervention (6 weeks)Upper limb motor function
Action Research Arm TestPost-intervention (6 weeks)Upper limb capacity

Other

MeasureTime frameDescription
Adverse EventsBaseline (0 week)Safety
Global Rating of Perceived ChangePost-intervention (6 weeks)
Concomitant movement therapyPost-intervention (6 weeks)Time spend at Movement therapy (e.g., Physiotherapy, Occupational therapy)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026